期刊文献+

Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients: 2008-2011 被引量:72

Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients: 2008-2011
原文传递
导出
摘要 Background Encephalopathy is a common complication of sepsis, and its onset can occur at any stage of sepsis and implies worse prognosis. However, the incidence, epidemiology, and pathogenesis of sepsis-associated encephalopathy remain controversial. The purpose of this study was to investigate the epidemiological features and risk factors for sepsis-associated encephalopathy. Background Encephalopathy is a common complication of sepsis, and its onset can occur at any stage of sepsis and implies worse prognosis. However, the incidence, epidemiology, and pathogenesis of sepsis-associated encephalopathy remain controversial. The purpose of this study was to investigate the epidemiological features and risk factors for sepsis-associated encephalopathy.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第5期828-831,共4页 中华医学杂志(英文版)
关键词 sepsis sepsis-associated encephalopathy epidemiology risk factor sepsis sepsis-associated encephalopathy epidemiology risk factor
  • 相关文献

参考文献1

二级参考文献29

  • 1Kris MG,Natale RB,Herbst RS,Lynch TJ Jr,Prager D,Belani CP,et al.Efficacy of gefitinib,an inhibitor of the epidermal growth factor receptor tyrosine kinase,in symptomatic patients with non-small cell lung cancer:a randomized trial.JAMA 2003; 290:2149-2158.
  • 2She Y,Lee F,Chen J,Haimovitz-Friedman A,Miller VA,Rusch VR,et al.The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates radiation response of human tumors in nude mice,with a marked improvement in therapeutic index.Clin Cancer Res 2003; 9:3773-3778.
  • 3Miya T.Radiation recall pneumonitis induced by Gefitinib (Iressa):a case report.Nihon Kokyuki Gakkai Zasshi 2003;41:565-568.
  • 4Macarty M J,Peake MF,Lillis P,Vukelja SJ.Paclitaxel induced radiation recall dermatitis.Med Pediatr Oncol 1996;27:185-186.
  • 5Morkas M,Fleming D,Hahl M.Challenges in oncology.Case 2. Radiation recall associated with docetaxel.J Clin Oncol 2002; 20; 867-869.
  • 6Kharfan Dabaja MA,Morgensztern D,Markoe AM,Bartlett-Pandite L.Radiation recall dermatitis induced by methotrexate in a patient with Hodgkin's disease.Am J Clin Oncol 2001; 24:211-213.
  • 7Burstein HJ.Side effects of chemotherapy.Case 1. Radiation recall dermatits from gemcitabine.J Clin Oncol 2000; 18;693-694.
  • 8Bianco C,Tortora G,Bianco R,Caputo R,Veneziani BM,Caputo R,et al.Enhancement of antitumor activity of ionizing radiation by combining treatment with the selective epidermal growth factor receptor tyrosine kinase inhibition ZD1839 (Iressa).Clin Cancer Res 2002; 8:3250-3258.
  • 9Abrey LE,DeAngelis LM,Yahalom J.Long-term survival in primary CNS lymphoma.J Clin Oncol 1998; 16:859-863.
  • 10Blay J,Conroy T,Chevreau C,Thyss A,Quesnel N,Eghbali H,et al.High-dose methotrexate for the treatment of primary cerebral lymphomas:analysis of survival and late neurologic toxicity in a retrospective series.J Clin Oncol 1998; 16:864-871.

共引文献3

同被引文献261

引证文献72

二级引证文献441

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部